"We are on a mission to reduce suffering and optimize wellness and are committed to shaping the future of psychedelic medicine in a responsible and accessible way," said Dr. Food and Drug Administration (FDA) approval, the New Clinic anticipates providing more psychedelic therapies and medicines including MDMA and psilocybin. The New Clinic enables client access to the Company's innovative, evidence-based therapies in individual and group settings, and will also serve as a key training site for clinicians. It thoughtfully incorporates design elements from Novamind's new flagship clinic concept that will be unveiled to the public in the near future. The New Clinic is purposefully planned and built to provide the most ideal setting to conduct psychedelic-assisted psychotherapy. Through strategic acquisitions and accelerated organic growth, Novamind anticipates expanding across other US states by the end of 2021. With the opening of the New Clinic, Novamind is on track to open four new locations in Utah by September 2021, doubling the size of its network to eight clinics.
The New Clinic is centrally located along the Wasatch Front, where the majority of Utah's population resides and will serve as a referral center for clients with treatment-resistant mental health conditions including depression, eating disorders, post-traumatic stress disorder (PTSD), and obsessive-compulsive disorder (OCD). (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has completed the construction of a new clinic focused on integrative psychiatric care and clinical research in Draper, Utah (the "New Clinic"). TORONTO, ON / ACCESSWIRE / J/ Novamind Inc. Company executes organic growth mandate, on track to open four new clinics by Q3 2021
0 kommentar(er)
